Bluedark

Amphetamine
Amphetamine
Salts
[]
Amphetamine sulfate
Amphetamine sulfate
Amphetamine hydrochloride
Amphetamine hydrochloride
Amphetamine aspartate
Amphetamine aspartate
Amphetamine adipate
Amphetamine adipate
Amphetamine tartrate
Amphetamine tartrate
Amphetamine acetate
Amphetamine acetate
Amphetamine chlorphenoxyacetate
Amphetamine chlorphenoxyacetate
Amphetamine phosphate
Amphetamine phosphate
Molecular structure via molpic
Molecular formulaC9H13N
Molecular mass135.21 g/mol
Density0.913 at 77 °F (EPA, 1998) - Less dense than water; will float g/cm3
AppearanceMobile liquid
OdorAmine odor
TasteAcrid, burning taste
Predicted LogP1.8
Melting point25 °C
Boiling point392 to 397 °F at 760 mmHg (EPA, 1998)
DecompositionWhen heated to decomposition it emits toxic fumes of nitroxides.
SolubilitySulfate: Soluble in water
Freebase: Soluble in ether, ethanol and chloroform
Chiralityracemic
Identifiers
[]
IUPAC name1-phenylpropan-2-amine
SMILESCC(CC1=CC=CC=C1)N
InChIInChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3
InChIKeyKWTSXDURSIMDCE-UHFFFAOYSA-N

Amphetamine

Amphetamine (also known as Amfetamine, Desoxynorephedrine, Norephedrane, 1-Phenyl-2-aminopropane, Elastonon, Fenopromin, Phenedrine, alpha-Methylphenethylamine, beta-Aminopropylbenzene or Propisamine and brand names including Adderall and Evekeo) is a stimulant substance of the amphetamine class.

History and culture

Amphetamine was first synthesized 1887 in Germany by Lazăr Edeleanu.

However, its effects remained unknown until 1927, when Gordon Alles discovered it to have stimulant properties.

Chemistry

Amphetamine is typically found in the form of its sulfate, hydrochloride, aspartate, adipate, tartrate, acetate, chlorphenoxyacetate and phosphate salts.

Amphetamine is a racemic mixture of two optical stereoisomers:

Stereoisomers
[]
DextroamphetamineLevoamphetamine
Dextroamphetamine Levoamphetamine

Pharmacology

Amphetamine acts as a monoamine releasing agent and monoamine reuptake inhibitor.

Enzyme activity

Amphetamine is a substrate of CYP2A6, coadministration of substances which inhibit CYP2A6 may result in altered drug effects and prolong its elimination half-life.

Subjective effects

Physical effects
[]

Cognitive effects
[]

Sensory effects
[]

See also